Celldex Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $142M | 5.5M | 25.87 |
| 2025-06-30 | $113M | 5.6M | 20.35 |
| 2025-03-31 | $100M | 5.5M | 18.15 |
| 2024-12-31 | $139M | 5.5M | 25.27 |
| 2024-09-30 | $166M | 4.9M | 33.99 |